0% found this document useful (0 votes)
53 views6 pages

Liz Draft

LIZ Pharmaceuticals PLC reported a revenue of ETB 99,146,738 for the year ended July 7, 2025, with a gross profit of ETB 11,680,764. The profit for the year increased to ETB 5,057,346 compared to ETB 4,975,332 in 2024. Total assets rose to ETB 67,118,504, while total equity and liabilities also matched this figure.

Uploaded by

Haile Kebede
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
53 views6 pages

Liz Draft

LIZ Pharmaceuticals PLC reported a revenue of ETB 99,146,738 for the year ended July 7, 2025, with a gross profit of ETB 11,680,764. The profit for the year increased to ETB 5,057,346 compared to ETB 4,975,332 in 2024. Total assets rose to ETB 67,118,504, while total equity and liabilities also matched this figure.

Uploaded by

Haile Kebede
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

LIZ PHARMACEUTICALS PLC

STATEMENT OF PROFIT OR LOSS


FOR THE YEAR ENDED 07 JULY, 2025

2025 2024
Notes ETB ETB

REVENUE 3 99,146,738 98,663,521

COST OF SALES 4 87,465,974 86,356,747

GROSS PROFIT 11,680,764 12,306,774

Other income - -
11,680,764 12,306,774

EXPENSES
Administration 5 3,443,486 3,928,907
Borrowing cost 6 484,438 751,203
3,927,924 4,680,110

PROFIT BEFORE TAX 7,752,840 7,626,664


Income tax expense 7 (2,695,494) (2,651,333)

PROFIT FOR THE YEAR 5,057,346 4,975,332


LIZ PHARMACEUTICALS PLC
STATEMENT OF FINANCIAL POSITION
AS AT 07 JULY, 2025
Note s
2025 2024
ETB ETB
ASSETS
NON-CURRENT ASSETS
Property, plant and equipment 8 48,759,559 22,899,040
48,759,559 22,899,040

CURRENT ASSETS
Trade and other receivables 9 428,568 3,037,291
Inventory 10 16,526,243 21,450,321
Cash and bank balances 11 1,404,134 2,071,415
18,358,945 26,559,027

TOTAL ASSETS 67,118,504 49,458,067

EQUITY AND LIABILITIES


CAPITAL AND RESERVES
Registered Capital 1 5,000,000 5,000,000
Proprietor account 2,853,867.92
Retained earning 31,768,584 10,171,893
39,622,452 15,171,893

NON-CURRENT LIABILITIES
Term loan-Non-current portion 12 10,452,895 11,129,434
10,452,895 11,129,434

CURRENT LIABILITIES
Trade and other payables 13 1,204,536 8,523,678
CBE OD Loan 4,985,632 5,000,000
Hibret Bank OD Loan 6,012,483
Current portion bank loan 2,145,013 6,981,731.00
Profit tax payables 7 2,695,494 2,651,333
17,043,158 23,156,742

TOTAL EQUITY AND LIABILITIES 67,118,504 49,458,067


LIZ PHARMACEUTICALS PLC
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 07 JULY, 2025

Registered Proprietor Retained Total


Capital account earning
ETB ETB ETB ETB

At 7 July 2024 5,000,000 10,171,893 15,171,893

Prior period adjustment - 2,853,868 16,539,345 19,393,213

Profit for the year - - 5,057,346 5,057,346

As at 7 July 2025 5,000,000 2,853,868 31,768,584 39,622,452


LIZ PHARMACEUTICALS PLC
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 07 JULY, 2025

2025 2024
ETB ETB
CASH FLOWS FROM OPERATING ACTIVITIES
Profit for the year before taxation 7,752,840 7,626,664

Adjustments for:
Prior period adjustment 16,539,345 2,179,574
Depreciation of property, plant and equipment and Amortization 2,371,351 2,161,336
26,663,536 11,967,574
Movements in working capital
(Increase)/decrease in inventory 2,939,793 9,098,930
(Increase)/decrease in trade and other receivables 1,804,773 8,464,327
Increase in trade and other payables (800,000) 839,985
Increase/(decrease)in profit tax payable (1,442,082) 614,832
Cash generated from operations 29,166,020 30,985,648

Profit tax paid (2,695,494) (2,651,333)

Net cash generated from operating activities 26,470,526 28,334,315

CASH FLOWS FROM INVESTING ACTIVITIES


Purchase of property, plant and equipment (27,622,665) (22,253,404)
Purchase of property, plant and equipment disposal - -
Net cash used in investing activities (27,622,665) (22,253,404)

CASH FLOWS FROM FINANCING ACTIVITIES


Owner withdrawal investment - (28,806,241)
Settlement of loan during the period 484,858 23,111,165
Proceeds/repayment of lease
Net cash used in financing activities 484,858 (5,695,076)

Net increase in cash and cash equivalents (667,281) 385,835


Cash and cash equivalents at 8 July 2,071,415 1,685,580
Cash and cash equivalents at 07 July 1,404,134 2,071,415

Represented by:
Bank and cash balances 1,404,134 2,071,415
1,404,134 2,071,415
LIZ PHARMACEUTICALS PLC
NOTES TO THE FINANCIAL STATEMENTS (continued)

3 REVENUE EXPORT LOCAL 2025 2024


SALES SALES ETB ETB

Sales 16,021,369 83,125,369 99,146,738 98,663,521


16,021,369 83,125,369 99,146,738 98,663,521

COST OF
4 OPRATION

Beginning Inventory 3,012,459 18,437,862 21,450,321 30,549,251


Raw Materials Costs 13,297,736 68,594,056 81,891,793 75,970,911
Less-Ending Inventory (3,001,457) (13,524,786) (16,526,243) (21,450,321)
13,308,738 73,507,132 86,815,871 85,069,841

Inspection 12,772 - 12,772


Fumigation 24,225 - 24,225
Transport 60,936 123,689 184,626 301,265
Loading & Unloading 14,630 43,180 57,810 75,638
Transit 13,405 - 13,405
Deprecation 176,515 176,515 353,031 898,979
Other 1,035 3,201 4,236 11,023
13,612,256 73,853,718 87,465,974 86,356,747

5 ADMINISTRATION

Salary Expense 419,037 608,095 1,027,132 1,096,038


Rent Expense 387,030 561,647 948,677 1,012,320
License and Registration 5,330 7,735 13,065 13,942
Office Supplier and
11,608 16,845 28,453 30,362
Sanitary items
Service Charge 6,049 8,778 14,826 15,821
Maintenance & Repairs
4,060 5,892 9,953 10,620
Expense
Communication Expense 4,512 6,853 11,365 40,320
Cleaning and sanitation 3,652 4,120 7,772 14,255
Utilities Expense 3,183 4,619 7,802 8,325
Insurance expense 50,925 73,901 124,826 133,200
Transportation Expense 6,366 9,238 15,603 16,650
Miscellaneous Expense 1,023 2,013 3,036 58,943
Fuel Expense 20,136 32,013 52,149 83,387
Other Expenses 7,123 6,523 13,646 132,369
Depreciation Expense 582,591 582,591 1,165,181 1,262,356
1,512,625 1,930,861 3,443,486 3,928,907
6 BORROWING COST

Interest 258,898 225,540 484,438 751,203


258,898 225,540 484,438 751,203
.
7 TAX EXPENSE COMPUTATION

Profitnon-
Add: before taxation
allowable 637,590 7,115,250 7,752,840 7,626,664
expenses -

- -
Less: Tax exempted income
Interest income on government bond
637,590 7,115,250 7,752,840 7,626,664

Tax expense for the year 205,156 2,472,337 2,695,494 2,651,333


Advance profit tax - -
At 7 July - Payable/(recoverable) 205,156 2,472,337 2,695,494 2,651,333
8 PROPERTY, PLANT AND EQUIPMENT

At 8 July As of 7 July,
2024 Additions Disposal 2025
COST ETB ETB ETB

Equipment 3,016,987 301,254 3,318,241


Motor vehicles 4,560,000 4,560,000
Office furniture 2,814,106 2,814,106
Computers and Accessories 625,600 85,369 710,969
Construction on Progress 14,253,698 27,236,042 41,489,740
25,270,391 27,622,665 52,893,056
DEPRECIATION

Equipment 663,450 486,712 1,150,162


Motor vehicles 964,082 719,184 1,683,266
Office furniture 584,117 445,998 1,030,115
Computers and Accessories 159,701 110,254 269,954
2,371,351 1,762,147 - 4,133,497

NET BOOK VALUE 22,899,040 48,759,559

TRADE AND OTHER EXPORT LOCAL 2025 2024


9 RECEIVABLES SALES SALES ETB ETB

Account Recievable - 151,203 151,203 1,023,646


VAT Recievable - 45,213 45,213 -
Deposit and per payment 133,520 98,632 232,152 2,013,645
133,520 295,048 428,568 3,037,291

10 INVENTORY

Stock 3,001,457 13,524,786 16,526,243 21,450,321


3,001,457 13,524,786 16,526,243 21,450,321

11 CASH AND BNK BALANCE

Cash on hand - 50,012 50,012 57,869.00


Cash at bank 600,002 754,120 1,354,122 2,013,546
600,002 804,132 1,404,134 2,071,415

12 LONG TERM LOAN


Payable More than one Year 7,965,321 4,632,587 12,597,908 13,985,853

7,965,321 4,632,587 12,597,908 13,985,853


TRADE AND OTHER
13 PAYABLES
VAT Payable -
Accrual - 1,204,536 1,204,536 8,523,678
- 1,204,536 1,204,536 8,523,678

You might also like